Transforming growth factor-beta receptor expression in human cornea

N C Joyce1, J D Zieske

  • 1Schepens Eye Research Institute and the Department of Ophthalmology, Harvard Medical School, Boston, Massachusetts 02114, USA.

Abstract

Insights

Human corneal and limbal cells express transforming growth factor-beta (TGF-beta) receptors, indicating they can respond to TGF-beta signals. This suggests TGF-beta may regulate cell cycle arrest in these ocular cells.

Area of Science:

  • Ophthalmology
  • Cell Biology
  • Molecular Biology

Background:

  • Limbal basal cells and corneal endothelial cells exhibit G1 phase cell cycle inhibition.
  • Transforming growth factor-beta (TGF-beta) is a potential mediator of this cell cycle inhibition.

Purpose of the Study:

  • To investigate the expression of TGF-beta receptor types I (RI), II (RII), and III (RIII) in human corneal and limbal cells.
  • To determine if these cells possess the necessary components to transduce TGF-beta signals.

Main Methods:

  • Human corneas from various ages were analyzed using indirect immunofluorescence for receptor protein localization.
  • Reverse transcription-polymerase chain reaction (RT-PCR) was employed to detect receptor mRNA in corneal epithelium and endothelium.

Main Results:

  • RI and RII were detected in limbal basal cells and corneal endothelium, with minimal expression in central corneal epithelium.
  • RIII was found in all corneal epithelium layers and suprabasal limbal layers, but decreased in limbal basal cells; corneal endothelium showed strong RIII staining.
  • Both mRNA and protein for all three TGF-beta receptor types were confirmed in corneal epithelium and endothelium.

Conclusions:

  • Human limbal basal cells and corneal endothelial cells express all three TGF-beta receptor types, suggesting they can receive TGF-beta signals.
  • Differential expression of RIII between limbal basal cells and corneal endothelium may indicate varied responses to specific TGF-beta isoforms.
  • The presence of TGF-beta receptors supports the hypothesis that TGF-beta mediates G1 phase arrest in these ocular cell types.

Related Concept Videos

Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
Regulation of Angiogenesis and Blood Supply01:24

Regulation of Angiogenesis and Blood Supply

Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits.  Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl hydroxylase and factor...
TGF - β Signaling Pathway01:16

TGF - β Signaling Pathway

The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors are of three kinds RI, RII, and RIII. The RI...